Business Model

Business Model

Business Model

Biophagy’s Business Model

Biophagy is managing a dual business model utilizing standard drug development programs in several therapeutic areas. It is also developing an over the counter (OTC) and/or direct to consumer (DTC) kit that will focus exclusively on autophagy stimulation and individual measurement of autophagy function over an extended period.

Proprietary Drug Discovery

  • Proprietary drug discovery with newly patented compounds developed for unmet medical needs, e.g., anti-microbial, neurodegenerative diseases.

CellWatch™

  • An OTC kit with a rationally designed proprietary mix designed to stimulate and measure autophagy.